XML 42 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stock Option And Stock Award Plans | 12 Months Ended
--- | ---
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
Stock Option And Stock Award Plans | STOCK OPTION AND STOCK AWARD PLANS Tredegar has one equity incentive plan under which stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. Employee options granted from 2012 to 2014 vested over a four-year period, with a quarter of the options granted vesting on each year on the grant date anniversary. Two stock option grants were made in 2017, with one cliff vesting after two years and the other cliff vesting after three years. No stock options were granted in 2015 and 2016. The option plan also permits the grant of stock appreciation rights (“SARs”), stock, restricted stock, stock unit awards and incentive awards. Restricted stock grants ordinarily vest three years from the date of grant based upon continued employment. Stock unit awards vest upon the achievement of certain performance targets. No SARs have been granted since 1992 and none are currently outstanding. A summary of stock options outstanding at December 31, 2017, 2016 and 2015, and changes during those years, is presented below:
|  |  | Option Exercise Price/Share
| Number of Options |  | Range |  | Weighted Average
Outstanding at January 1, 2015 | 1,164,120 |  |  | $ | 14.06 |  |  | to |  | $ | 30.01 |  |  | $ | 19.59 |
Granted | — |  |  | — |  |  | to |  | — |  |  | — |
Forfeited and expired | (60,207 | ) |  | 17.13 |  |  | to |  | 30.01 |  |  | 22.30 |
Exercised | (222,400 | ) |  | 14.06 |  |  | to |  | 19.84 |  |  | 16.34 |
Outstanding at December 31, 2015 | 881,513 |  |  | 17.13 |  |  | to |  | 30.01 |  |  | 20.22 |
Granted | — |  |  | — |  |  | to |  | — |  |  | — |
Forfeited and expired | (246,394 | ) |  | 17.13 |  |  | to |  | 30.01 |  |  | 18.90 |
Exercised | (134,200 | ) |  | 17.13 |  |  | to |  | 19.84 |  |  | 17.23 |
Outstanding at December 31, 2016 | 500,919 |  |  | 17.13 |  |  | to |  | 30.01 |  |  | 21.67 |
Granted | 209,551 |  |  | 15.65 |  |  | to |  | 15.65 |  |  | 15.65 |
Forfeited and expired | (60,685 | ) |  | 17.13 |  |  | to |  | 30.01 |  |  | 21.42 |
Exercised | (41,265 | ) |  | 19.84 |  |  | to |  | 19.84 |  |  | 19.84 |
Outstanding at December 31, 2017 | 608,520 |  |  | $ | 15.65 |  |  | to |  | $ | 24.84 |  |  | $ | 19.75 |
The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2017:
|  |  |  |  |  | Options Outstanding at December 31, 2017 |  | Options Exercisable at December 31, 2017
|  |  |  |  |  |  |  | Weighted Average |  | Aggregate Intrinsic Value (In thousands) |  |  |  |  |  | Aggregate Intrinsic Value (In thousands)
Range of Exercise Prices |  | Shares |  | Remaining Contractual Life (Years) |  | Exercise Price |  |  | Shares |  | Weighted Average Exercise Price |
$ | — |  |  | to |  | $ | 15.00 |  |  | — |  |  | 0.0 |  | $ | — |  |  | $ | — |  |  | — |  |  | $ | — |  |  | $ | — |
15.01 |  |  | to |  | 17.50 |  |  | 209,551 |  |  | 6.4 |  | 15.65 |  |  | 743,906 |  |  | — |  |  | — |  |  | — |
17.51 |  |  | to |  | 20.00 |  |  | 171,460 |  |  | 2.2 |  | 19.58 |  |  | 429 |  |  | 171,460 |  |  | 19.58 |  |  | 429 |
20.01 |  |  | to |  | 25.00 |  |  | 227,509 |  |  | 5.6 |  | 23.64 |  |  | — |  |  | 214,198 |  |  | 23.71 |  |  | — |
Total |  | 608,520 |  |  | 4.9 |  | $ | 19.75 |  |  | $ | 744,335 |  |  | 385,658 |  |  | $ | 21.88 |  |  | $ | 429 |
During 2015, the Board of Directors approved the accelerated vesting of stock options and restricted stock for several Tredegar executives who left the Company. Compensation expense recognized in 2015 for accelerated stock option vestings (0.4 million shares) and accelerated restricted stock vestings (0.1 million shares) totaled $0.4 million and $1.0 million, respectively. The following table summarizes additional information about unvested restricted stock outstanding at December 31, 2017, 2016 and 2015:
| Unvested Restricted Stock |  | Maximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria
| Number of Shares |  | Weighted Avg. Grant Date Fair Value/Share |  | Grant Date Fair Value (In thousands) |  | Number of Shares |  | Weighted Avg. Grant Date Fair Value/Share |  | Grant Date Fair Value (In thousands)
Outstanding at January 1, 2015 | 188,058 |  |  | $ | 22.48 |  |  | $ | 4,227 |  |  | 129,713 |  |  | $ | 24.99 |  |  | $ | 3,241 |
Granted | 147,666 |  |  | 18.87 |  |  | 2,786 |  |  | 144,582 |  |  | 18.47 |  |  | 2,670 |
Vested | (174,145 | ) |  | 20.57 |  |  | (3,582 | ) |  | — |  |  | — |  |  | — |
Forfeited | (29,226 | ) |  | 21.42 |  |  | (626 | ) |  | (107,167 | ) |  | 20.78 |  |  | (2,227 | )
Outstanding at December 31, 2015 | 132,353 |  |  | 21.19 |  |  | 2,805 |  |  | 167,128 |  |  | 22.04 |  |  | 3,684 |
Granted | 144,546 |  |  | 13.47 |  |  | 1,947 |  |  | 136,986 |  |  | 11.34 |  |  | 1,553 |
Vested | (52,167 | ) |  | 21.56 |  |  | (1,125 | ) |  | — |  |  | — |  |  | — |
Forfeited | (17,377 | ) |  | 18.97 |  |  | (330 | ) |  | (65,685 | ) |  | 20.24 |  |  | (1,329 | )
Outstanding at December 31, 2016 | 207,355 |  |  | 15.90 |  |  | 3,297 |  |  | 238,429 |  |  | 16.39 |  |  | 3,908 |
Granted | 107,362 |  |  | 18.29 |  |  | 1,964 |  |  | 46,205 |  |  | 17.38 |  |  | 803 |
Vested | (50,154 | ) |  | 19.72 |  |  | (989 | ) |  | — |  |  | — |  |  | — |
Forfeited | (57,887 | ) |  | 16.16 |  |  | (935 | ) |  | (112,501 | ) |  | 17.73 |  |  | (1,995 | )
Outstanding at December 31, 2017 | 206,676 |  |  | $ | 16.15 |  |  | $ | 3,337 |  |  | 172,133 |  |  | $ | 15.78 |  |  | $ | 2,716 |
The total intrinsic value of stock options exercised was $0.2 million in 2017, $0.2 million in 2016 and $1.0 million in 2015. The grant-date fair value of stock option-based awards vested was $0.4 million in 2017, $0.4 million in 2016 and $1.9 million in 2015. As of December 31, 2017, there was unrecognized compensation cost of $0.6 million related to stock option-based awards and $2.2 million related to non-vested restricted stock and other stock-based awards. This cost is expected to be recognized over the remaining weighted average period of 1.65 years for stock option-based awards and 1.3 years for non-vested restricted stock and other stock-based awards. Stock options exercisable totaled 385,658 at December 31, 2017 and 453,067 shares at December 31, 2016. Stock options available for grant totaled 1,704,554 shares at December 31, 2017.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration